The WACC of MYND Life Sciences Inc (MYND.CN) is 3.4%.
| Range | Selected | |
| Cost of equity | 1.20% - 4.00% | 2.60% |
| Tax rate | 0.70% - 2.80% | 1.75% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 4.3% - 2.5% | 3.4% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | -3.77 | -3.77 |
| Additional risk adjustments | 20.0% | 20.5% |
| Cost of equity | 1.20% | 4.00% |
| Tax rate | 0.70% | 2.80% |
| Debt/Equity ratio | 0.57 | 0.57 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 4.3% | 2.5% |
| Selected WACC | 3.4% | |